Prostaglandin-endoperoxide synthase 2 (PTGS2) might mediate the CXCR2 signaling to inversely control the breast cancer metastasis and chemoresistance through the regulation of EMT, apoptosis, and senescence (Xu et al., 2018). This evidence concerns the gene CXCR2 and breast carcinoma.